Biosimilars: Market Insights and Growth Factors
The growth of biosimilars presents a significant opportunity to reduce the cost of care and provide patients with greater access to affordable treatments. Our experts assess the current state and future of the biosimilars market.
Biosimilars: Launch Insights From the Field
How are biosimilar manufacturers approaching patients, providers and payers? What can they do to differentiate? Xcenda shares insight from our field programs.
Biosimilars: Shaping a Moving Market
An animated, immersive biosimilar market snapshot with actionable insight for manufacturers.
Biosimilars Check Up: Physician Survey Results
We asked 100 physicians to share their perspectives on biosimilar utilization, cost savings, and adoption barriers. See what they said and what it means for the market and manufacturers.
Biosimilars: Key Considerations
As biosimilars launch, they are shaping the treatment landscape. These new options are also creating new opportunities for health system pharmacy leaders to expand their influence on patient outcomes.
Affordability and Access Will Drive Biosimilar Success
U.S. biosimilars are coming, just as they’ve arrived and prospered in the Europe. By ensuring positive patient experiences, specialty pharmacies will help usher in a sustainable wave of biosimilar products.
Four Questions That Will Move Pharma Forward
Key themes from ThinkLive 2017, AmerisourceBergen's annual manufacturer summit.
The Growth of Biosimilars in the Oncology Pipeline
What should biosimilar manufacturers focus on for commercialization success?
Success Factors for Commercializing Biosimilars
Three factors that could influence biosimilars' commercial success.
Improving Customer Experience and Driving Long-Term Value for Manufacturers
Rich Tremonte on the current healthcare landscape, the role of the wholesaler and how the new organizational structure at AmerisourceBergen brings out the best in both.